NYSE · Health Care

ZIMMER BIOMET HOLDINGS INC ZBH

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

Industrial Specialties

Company profile

Business mix

  • The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
  • products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products.
  • It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
  • The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within medical devices?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 1 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 22.64 FCF 6.74% Buyback 2.25%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Oakmark / Harris Associates Bill Nygren 1.6% $1.2B 2026-03-31

Recent trading changes over the last 4 quarters

Net buyers 2 Last 4 13F filing periods
Net reducers 0 Last 4 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $1.2B Estimated from net added shares
Reduction amount $0 Estimated from net reduced shares
Net share change / base shares New +12,963,168 / 0
Oakmark / Harris Associates Bill Nygren 4 filing periods
13F 2025-06-30 Filed 2025-08-14
New Shares - 13F value change +$340.4M
13F 2025-09-30 Filed 2025-11-14
Major increase Shares 27.3% 13F value change +$127.5M
13F 2025-12-31 Filed 2026-02-17
Major increase Shares 158.2% 13F value change +$634.9M
13F 2026-03-31 Filed 2026-05-15
Minor increase Shares 5.7% 13F value change +$69.0M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 0 Last 4 periods +12,959,939 (New) Total shares 12,959,939 Value $1.2B
Ariel Investments John Rogers 4 filing periods
13F 2025-03-31 Filed 2025-05-15
New Shares - 13F value change +$33.9M
13F 2025-06-30 Filed 2025-08-14
Major reduction Shares -15.6% 13F value change -$10.9M
13F 2025-09-30 Filed 2025-11-14
Major increase Shares 55.9% 13F value change +$15.8M
13F 2025-12-31 Filed 2026-02-13
Major reduction Shares -99.2% 13F value change -$38.6M
Settlement As of 13F 2025-12-31 · Filed 2026-02-13
Base shares 0 Last 4 periods +3,229 (New) Total shares 3,229 Value $290,352

Recent mentions

No public mentions.